Novel amino-modified silica nanoparticles as efficient vector for hepatocellular carcinoma gene therapy

Medical Oncology

Volumn 27, Issue 4, 2010, Pages 1200-1207

  Xiao, Xuxian ^a   He, Qiongqiong ^b   Huang, Kelong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Amino modified silica nanoparticles (AMSNs); Gene therapy; Gene transfer; Hepatocellular carcinoma (HCC); Nonviral vector

Indexed keywords

AMINO MODIFIED SILICA NANOPARTICLE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; NANOCARRIER; NANOPARTICLE; PROTEIN P53; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA DEGRADATION; DNA TRANSFER; FEMALE; GENE DELIVERY SYSTEM; GENE VECTOR; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SILICON DIOXIDE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951769313     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9359-9     Document Type: Article

References (30)

1. Müller C. Hepatocellular carcinoma-rising incidence, changing therapeutic strategies. Wien Med Wochenschr. 2006;156:404-9. (Pubitemid 44182027)
2. Jen CP, et al. A nonviral transfection approach in vitro: the design of a gold nanoparticle vector joint with microelectromechanical systems. Langmuir. 2004;20:1369-74.
3. Welzel T, Radtke I, Meyer-Zaika W, Heumann R, Epple M. Transfection of cells with custom-made calcium phosphate nanoparticles coated with DNA. J Mater Chem. 2004;14:2213-7.
4. Chung TH, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials. 2007;28:2959-66.
5. Yan SF, et al. Surface-grafted silica linked with l-lactic acid oligomer: a novel nanofiller to improve the performance of biodegradable poly (l-lactide). Polymer. 2007;48:1688-94.
6. Kim MI, et al. Immobilization of Mucor javanicus lipase on effectively functionalized silica nanoparticles. J Mol Catal B: Enzym. 2006;39:62-8.
7. Park ME, Chang JH. High throughput human DNA purification with aminosilanes tailored silica-coated magnetic nanoparticles. Mat Sci Eng: C. 2007;27:1232-5. (Pubitemid 47211861)
8. Chiang CL, Sung CS, Chen CY. Application of silica-magnetite nanocomposites to the isolation of ultrapure plasmid DNA from bacterial cells. J Magn Magn Mater. 2006;305:483-90.
9. He XX, et al. Plasmid DNA isolation using amino-silica coated magnetic nanoparticles (ASMNPs). Talanta. 2007;73:764-9.
10. Yang W, Zhang CG, Qu HY, Yang HH, Xu JG. Novel fluorescent silica nanoparticle probe for ultrasensitive immunoassays. Anal Chim Acta. 2004;503:163-9. (Pubitemid 38032935)
11. 2+-doped silica nanoparticle aptasensor via target protein-induced strand displacement. Anal Chim Acta. 2007;598:242-8.
12. Kneuer C, et al. Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int J Pharm. 2000;196:257-61. (Pubitemid 30105756)
13. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007;26:2166-76. (Pubitemid 46536641)
14. Staib F, Hussain SP, Hofseth LJ. TP53 and liver carcinogenesis. Hum Mutat. 2003;21:2012-6.
15. Guan YS, La Z, Yang L, He Q, Li P. p53 gene in treatment of hepatic carcinoma: status quo. World J Gastroenterol. 2007;13:985-92. (Pubitemid 46510997)
16. Haupt S, Haupt Y. Importance of p53 for cancer onset and therapy. Anticancer Drug. 2006;17:725-32. (Pubitemid 44310170)
17. Plumeré N, Speiser B. Redox-active silica nanoparticles: part 2. Photochemical hydrosilylation on a hydride modified silica particle surface for the covalent immobilization of ferrocene. Electrochim Acta. 2007;53:1245-52. (Pubitemid 47614980)
18. Major RC, Zhu XY. Two-step approach to the formation of organic monolayers on the silicon oxide surface. Langmuir. 2001;17:5576-80. (Pubitemid 35330796)
19. Varbiro G, Veres B, Gallyas F Jr, Sumegi B. Direct effect of taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med. 2001;31:548-58. (Pubitemid 32728442)
20. He QQ, et al. Cell transformation and proteome alteration in QSG7701 cells transfected with hepatitis C virus non-structural protein 3. Acta Biochim Biophys Sin. 2007;39:751-62.
21. Sadasivan S, Rasmussen DH, Chen FP, Kannabiran RK. Preparation and characterization of ultrafine silica. Colloid Surface A. 1998;132:45-52. (Pubitemid 28138586)
22. Chen Y, et al. Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. Curr Gene Ther. 2003;3:273-9.
23. He XX, et al. A novel DNA-enrichment technology based on aminomodified functionalised silica nanoparticles. J Disper Sci Technol. 2003;24:633-40.
24. Zhu SG, et al. Poly (L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides. Biotechnol Appl Bioc. 2004;39:179-87.
25. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalized carbon nanotubes. Chem Commun. 2005;5:571-7. (Pubitemid 40299037)
26. El Far MA, Atwa MA, Yahya RS, El Basuni MA. Evaluation of serum levels of p53 in hepatocellular carcinoma in Egypt. Clin Chem Lab Med. 2006;44:653-6. (Pubitemid 43735642)
27. Horowitz J. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications. Curr Opin Mol Ther. 1999;1:500-9. (Pubitemid 29420047)
28. Guo Y, et al. Therapeutic potential of recombinant adenovirus expressing p53 in hepatocellular carcinoma cell lines. Zhonghua Ganzangbing Zazhi. 2001;9: S43-5.
29. Wang W, Rastinejad F, El-Deiry WS. Restoring p53-dependent tumor suppression. Cancer Biol Ther. 2003;2: S55-63.
30. Nowling T, Desler M, Kuszynski C, Rizzino A. Transfection of embryonal carcinoma cells at efficiency using liposome-mediated transfection. Mol Reprod Dev. 2002;63:309-17.